Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Latest filing published 23 Jul 2026 for Adaptive Biotechnologies Corp, €1.6M. Read the official filing
Filing timeline
BuySaleHarlan S. Robins
Insider track record
Disclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Harlan S. Robins: trading record in brief
Harlan S. Robins is a declared insider of Adaptive Biotechnologies Corp (senior executive), with filings sourced from SEC (Form 4). In total, 31 filings cover trades dated from 4 May 2021 to 21 July 2026.
Every open-market trade on record is a sale: 13 sales worth €20.0M. The amount is not disclosed for 2 filings. Other entries cover 5 share grants and 13 option exercises. So far in 2026, the count stands at no purchases and 11 sales.
The record was last updated on 23 July 2026 with an option exercise (€1.6M) in Adaptive Biotechnologies Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Harlan S. Robins
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
284,800 shares@ US$6.550.051% mcap7.4% of flowCommon StockSEC:0001780851-26-000017:0
278,698 shares@ US$21.720.17% mcap23.9% of flowCommon StockSEC:0001780851-26-000017:1
213,702 shares@ US$22.120.13% mcap18.6% of flowCommon StockSEC:0001780851-26-000017:2
239,351 shares@ US$21.740.15% mcap41.4% of flowCommon StockSEC:0001780851-26-000015:0
146,889 shares@ US$22.450.097% mcap26.3% of flowCommon StockSEC:0001780851-26-000015:1
100,000 sharesCommon StockSEC:0001780851-26-000013:0
6,160 sharesCommon StockSEC:0001780851-26-000013:1
10,000 shares@ US$14.850.0062% mcap4.0% of flowCommon StockSEC:0001780851-26-000011:0
140,666 shares@ US$13.1714.3% of flowCommon StockSEC:0001780851-26-000007:0
127,813 shares0Common StockSEC:0001780851-26-000005:0
10,000 shares@ US$15.720.0065% mcap4.2% of flowCommon StockSEC:0001780851-26-000003:0
34,668 shares@ US$18.600.027% mcap17.2% of flowCommon StockSEC:0001780851-26-000002:0
10,000 shares@ US$16.440.0068% mcap4.4% of flowCommon StockSEC:0001780851-26-000001:0
27,212 shares@ US$18.610.021% mcap13.8% of flowCommon StockSEC:0001780851-25-000003:0
10,000 shares@ US$14.821.3% of flowCommon StockSEC:0001780851-25-000002:0
68,412 shares@ US$6.3210.8% of flowCommon StockSEC:0001062993-25-008509:0
1,698 shares@ US$6.320.3% of flowCommon StockSEC:0001062993-25-006335:0
355,000 shares0Common StockSEC:0001062993-25-004810:0
354,610 shares0Common StockSEC:0001062993-24-005760:0
354,610 shares0Common StockSEC:0001062993-23-006322:0
247,117 shares0Common StockSEC:0001209191-22-017394:0
3,700 shares@ US$6.550.0010% mcap0.7% of flowCommon StockSEC:0001209191-21-065839:0
3,800 shares@ US$6.550.0010% mcap0.7% of flowCommon StockSEC:0001209191-21-061319:0
3,895 shares@ US$6.320.0010% mcap0.7% of flowCommon StockSEC:0001209191-21-060115:0
3,895 shares@ US$6.320.1% of flowCommon StockSEC:0001209191-21-056261:0
25 of 31 declarations
